Shorter tuberculosis treatment for children
Treatments studied
Part of Infections clinical trials.
This study tests if a shorter course of tuberculosis (TB) medicine works as well as the current longer treatment for children. If successful, it means fewer days of medicine and fewer side effects for kids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 3 months and 10 years old.
- Your child weighs at least 3 kilograms (about 6.6 pounds) and less than 45 kilograms (about 99 pounds).
- Your child has TB in the chest or certain forms outside the chest, confirmed by a test or by a doctor's assessment.
- If your child has HIV, they must be on a specific HIV medicine called dolutegravir.
- Your child has not started TB treatment for more than 5 days.
- Your child does not have TB in the brain, bones, or a severe form called miliary TB.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
This study tests a daily combination of two medicines, rifapentine and isoniazid, to prevent tuberculosis (TB) in children under 13 years old. It aims to see if this short treatment is safe and works well for kids, including those living with HIV.
This trial tests a new, all-oral, shorter treatment regimen for tuberculosis that is resistant to rifampicin, a key antibiotic. It may offer a more convenient and effective option for patients with this difficult-to-treat infection.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests shorter treatment plans for tuberculosis (TB) in Kazakhstan. It aims to see if a newer drug combination can cure TB or TB infection faster and with fewer side effects.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.